For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
search
Quick Order bolt
Request Quote sms
Applications
Infliximab on bioZen 1.8 µm SEC-3
24764
Separation Mode: Size Exclusion
Size Exclusion
SEC-3
HPLC
Pharmaceutical/Biopharmaceutical
Life Science
Therapeutic / Clinical
Therapeutic / Clinical

Infliximab on bioZen 1.8 µm SEC-3

zoom_in
Analytes
1Infliximab
Details
LC Conditions (App ID: 24764)
Column:
Brand Name:
bioZen
Part No:
Phase Name:
SEC-3
Similar Applications
No Data
Phenomenex
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
Danaher
Connect With Us
Phenomenex
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.

Products and Services

Products

Techniques

Industries

Quick Order

Support

Product/Method Support

Troubleshooting Help

Contact Us

CQA / CofA

Our company

About Phenomenex

Knowledge Center

News

Danaher Life Sciences

Terms and Conditions Privacy Statement Quality Policy Terms of Use Trademarks CA Supply Chains Act CA Consumer Privacy Act Cookie Policy Impressum
© 2025  Phenomenex Inc. All rights reserved.